1. Home
  2. SBFM vs AQB Comparison

SBFM vs AQB Comparison

Compare SBFM & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • AQB
  • Stock Information
  • Founded
  • SBFM 2006
  • AQB 1991
  • Country
  • SBFM United States
  • AQB United States
  • Employees
  • SBFM N/A
  • AQB N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • AQB
  • Sector
  • SBFM Health Care
  • AQB
  • Exchange
  • SBFM Nasdaq
  • AQB Nasdaq
  • Market Cap
  • SBFM 7.7M
  • AQB 2.9M
  • IPO Year
  • SBFM N/A
  • AQB N/A
  • Fundamental
  • Price
  • SBFM $1.54
  • AQB $0.75
  • Analyst Decision
  • SBFM Strong Buy
  • AQB
  • Analyst Count
  • SBFM 1
  • AQB 0
  • Target Price
  • SBFM $15.00
  • AQB N/A
  • AVG Volume (30 Days)
  • SBFM 183.8K
  • AQB 215.4K
  • Earning Date
  • SBFM 08-15-2025
  • AQB 08-05-2025
  • Dividend Yield
  • SBFM N/A
  • AQB N/A
  • EPS Growth
  • SBFM N/A
  • AQB N/A
  • EPS
  • SBFM N/A
  • AQB N/A
  • Revenue
  • SBFM $36,234,578.00
  • AQB N/A
  • Revenue This Year
  • SBFM $192.48
  • AQB N/A
  • Revenue Next Year
  • SBFM N/A
  • AQB N/A
  • P/E Ratio
  • SBFM N/A
  • AQB N/A
  • Revenue Growth
  • SBFM 35.51
  • AQB N/A
  • 52 Week Low
  • SBFM $1.17
  • AQB $0.47
  • 52 Week High
  • SBFM $7.60
  • AQB $1.94
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 53.29
  • AQB 47.16
  • Support Level
  • SBFM $1.42
  • AQB $0.70
  • Resistance Level
  • SBFM $1.75
  • AQB $0.80
  • Average True Range (ATR)
  • SBFM 0.12
  • AQB 0.07
  • MACD
  • SBFM 0.01
  • AQB -0.01
  • Stochastic Oscillator
  • SBFM 44.44
  • AQB 28.02

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: